5MJC RCCU 2: Everolimus in Patients with Cytokine-Pretreated mRCC
Everolimus in Patients with Cytokine-Pretreated mRCC
5MJC RCCU 1: Presurgical Feasibility of Bevacizumab for Nephrectomy-Eligible, Treatment-Naïve Patients with Metastatic Renal Cell Carcinoma
Presurgical Feasibility of Bevacizumab for Nephrectomy-Eligible, Treatment-Naïve Patients with Metastatic Renal Cell Carcinoma
Subscription | Sign up to receive your complimentary copy of Breast Cancer Update Think Tank
If you would like to to receive immediate notification and a link to download our Breast Cancer Update Think Tank program when it’s available online, or to receive the program by mail in hard copy with audio CDs†, please take a moment to fill out the brief form below and indicate your preference of email, hard copy or both.
†Hard copy by mail currently available to practicing US clinicians only.
* This field is required.
Subscription | Sign up to receive your complimentary copy of Renal Cell Think Tank
If you would like to to receive immediate notification and a link to download our Renal Cell Think Tank program when it’s available online, or to receive the program by mail in hard copy with audio CDs†, please take a moment to fill out the brief form below and indicate your preference of email, hard copy or both.
†Hard copy by mail currently available to practicing US clinicians only.
* This field is required.